Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 21Active not recruiting 8Not yet recruiting 6Terminated 4Completed 4Enrolling by invitation 2Suspended 1Available 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 51Breast Neoplasms 40Colorectal Neoplasms 26Prostatic Neoplasms 22Lung Neoplasms 18Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 15Stomach Neoplasms 14Brain Neoplasms 11Hematologic Neoplasms 10Pancreatic Neoplasms 9Colonic Neoplasms 9Uterine Cervical Neoplasms 8Urinary Bladder Neoplasms 8Lymphoma, Follicular 8Head and Neck Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Ovarian Neoplasms 7Melanoma 7Liver Neoplasms 7Leukemia, Myeloid, Acute 7Disease 7Anxiety Disorders 7Myasthenia Gravis 6Multiple Myeloma 6Barrett Esophagus 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Rectal Neoplasms 5Lymphoma, Non-Hodgkin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Epstein-Barr Virus Infections × 1 year × Clear all
NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Emory University

Enrolling by invitation
2,500 enrolled

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

NCT06027879 2025-06-25

Gamma Capture

University of Pittsburgh

Phase 1/2 Enrolling by invitation
25 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡